Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cyto-Sen Therapeutics, Inc., a biopharmaceutical company, develops natural killer cells with its particle-based expansion and activation process to treat cancer. It produces cellular immunotherapeutics to treat cancers through personalized and universal donor sources. Cyto-Sen Therapeutics, Inc. has a strategic partnership with KBI Biopharma. The company was founded in 2014 and is based in Orlando, Florida. As of June 6, 2019,...
Cyto-Sen Therapeutics, Inc., a biopharmaceutical company, develops natural killer cells with its particle-based expansion and activation process to treat cancer. It produces cellular immunotherapeutics to treat cancers through personalized and universal donor sources. Cyto-Sen Therapeutics, Inc. has a strategic partnership with KBI Biopharma. The company was founded in 2014 and is based in Orlando, Florida. As of June 6, 2019, Cyto-Sen Therapeutics, Inc. operates as a subsidiary of Kiadis Pharma N.V.

List your booth number for exhibitions, ask us